KR880001643A - 허혈성 혈관 질병 치료방법 - Google Patents

허혈성 혈관 질병 치료방법 Download PDF

Info

Publication number
KR880001643A
KR880001643A KR1019870006952A KR870006952A KR880001643A KR 880001643 A KR880001643 A KR 880001643A KR 1019870006952 A KR1019870006952 A KR 1019870006952A KR 870006952 A KR870006952 A KR 870006952A KR 880001643 A KR880001643 A KR 880001643A
Authority
KR
South Korea
Prior art keywords
carbon atoms
alkoxy
alkyl
compound
cycloalkyl
Prior art date
Application number
KR1019870006952A
Other languages
English (en)
Korean (ko)
Inventor
노르트 프랑크
Original Assignee
제랄드 디. 샤르킨
산도즈 파마슈티칼스 코오포레이숀
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제랄드 디. 샤르킨, 산도즈 파마슈티칼스 코오포레이숀 filed Critical 제랄드 디. 샤르킨
Publication of KR880001643A publication Critical patent/KR880001643A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019870006952A 1986-07-01 1987-07-01 허혈성 혈관 질병 치료방법 KR880001643A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8616047 1986-07-01
GB868616047A GB8616047D0 (en) 1986-07-01 1986-07-01 A 1 4-dihydropyridine derivatives

Publications (1)

Publication Number Publication Date
KR880001643A true KR880001643A (ko) 1988-04-25

Family

ID=10600369

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870006952A KR880001643A (ko) 1986-07-01 1987-07-01 허혈성 혈관 질병 치료방법

Country Status (10)

Country Link
JP (1) JPS6322519A (it)
KR (1) KR880001643A (it)
AU (1) AU7491487A (it)
DE (1) DE3720509A1 (it)
DK (1) DK333587A (it)
FR (1) FR2601012A1 (it)
GB (2) GB8616047D0 (it)
IT (1) IT1216830B (it)
SE (1) SE8702697L (it)
ZA (1) ZA874768B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat

Also Published As

Publication number Publication date
DK333587A (da) 1988-01-02
IT8748101A0 (it) 1987-06-25
ZA874768B (en) 1989-02-22
GB8616047D0 (en) 1986-08-06
DK333587D0 (da) 1987-06-29
SE8702697L (sv) 1988-01-02
IT1216830B (it) 1990-03-14
SE8702697D0 (sv) 1987-06-30
AU7491487A (en) 1988-01-07
GB8715219D0 (en) 1987-08-05
FR2601012A1 (fr) 1988-01-08
GB2192132A (en) 1988-01-06
DE3720509A1 (de) 1988-01-28
JPS6322519A (ja) 1988-01-30

Similar Documents

Publication Publication Date Title
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
KR890011592A (ko) 기관내 허혈병의 치료용 조성물
KR880006193A (ko) 피페리딘 화합물 및 그의 제조 및 용도
KR900016174A (ko) 과혈당증 치료제로서 유용한 나프탈레닐알킬-3h-1,2,3,5-옥사티아디아졸 2-옥사이드
RU94022743A (ru) Амидо- или карбамидо-производные, обладающие антигиперхолестериновой активностью, и фармацевтическая композиция на их основе
KR900015718A (ko) 골관절염 치료제
KR920019798A (ko) 라파마이신 카바메이트
KR880009948A (ko) 항 알레르기 및 항 염증제로서 용도를 갖는 신규의 나프탈렌 유도체
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
KR890003691A (ko) 피페리딘 유도체 및 그를 함유하는 부정맥을 위한 치료예방제
KR900018027A (ko) 피페리딘 유도체, 그의 제조 방법, 및 그것을 유효성분으로 함유하는 의약용 조성물
KR920004387A (ko) 진통제 및 피부질환 치료용 국소용 소염제로서의 4-치환된 디하이드로피리도[4,3-d]피리미딘
AU3623399A (en) Use of benzofuroxan derivatives in treating angina pectoris
KR880001643A (ko) 허혈성 혈관 질병 치료방법
KR900012903A (ko) 피롤리딘 화합물 및 약제학적 용도
KR910011807A (ko) 4-벤질-5-페닐-2,4-디히드로-3h-1,2,4-트리아졸-3-온 및 진경제로서의 그 의 용도
KR890006621A (ko) 항불안제
KR880009944A (ko) 피페라진 카르복실산, 그의 제조방법 및 그를 함유하는 약학적 조성물
NO173137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser
KR890012942A (ko) 5-치환된 오르니틴 유도체
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
KR880004810A (ko) 소화성 궤양 치료제
TR200102087T2 (tr) Yeni morfolinbenzamid tuzları
KR910002456A (ko) 당뇨병 치료용 제약 조성물
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid